Jamie Erickson

1.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Jamie Erickson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jamie Erickson has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jamie Erickson's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (3 papers). Jamie Erickson is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (3 papers). Jamie Erickson collaborates with scholars based in United States, United Kingdom and Canada. Jamie Erickson's co-authors include Jian Liu, David Howland, Louis J. DeGennaro, Benjamin Kim, John Kulik, George Psaltis, Nicholas J. Maragakis, Don W. Cleveland, Jeffrey D. Rothstein and Jason R. Gunn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Jamie Erickson

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

2002 660 citations David Howland, Jian Liu et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jamie Erickson

Since Specialization

Citations

This map shows the geographic impact of Jamie Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Erickson more than expected).

Fields of papers citing papers by Jamie Erickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Erickson. The network helps show where Jamie Erickson may publish in the future.

Co-authorship network of co-authors of Jamie Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Erickson. A scholar is included among the top collaborators of Jamie Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Erickson. Jamie Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40 2020 ·PLoS ONE ·(unknown), Sean W. Graham, Ning Sun, Donna McCarthy, (unknown), Jamie Erickson, (unknown), Xiaochun Zhu, (unknown), Robert W. Dunstan, Susan V. Westmoreland, Namjin Chung, Tariq Ghayur, Jijie Gu	5
2	Su2034 - Anti-CD40 Agonist MABS Mediate Activation and Recruitment of Both Innate and Adaptive Immune Cells in the Intestinal Mucosa of Immuno-Competent Wild-Type Mice 2018 ·Gastroenterology ·Marc‐André Wurbel, (unknown), Jamie Erickson, Robert W. Dunstan, (unknown), Anthony Slavin, Rajesh V. Kamath	1
3	Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration 2018 ·mAbs ·(unknown), Annette Schwartz, Farid Gizatullin, Jamie Erickson, Kangwen Deng, (unknown), (unknown), (unknown), Tariq Ghayur, Andrew Goodearl	35
4	Analysis of chloroquine and metabolites directly from whole‐body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry 2012 ·Journal of Mass Spectrometry ·(unknown), Stormy L. Koeniger, Robert W. Johnson, Jamie Erickson, Yu Tian, (unknown), Annette Schwartz, Edit Tarcsa, (unknown), Gary J. Van Berkel	41
5	The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity 2009 ·The Journal of Immunology ·Philip D. Bardwell, Jijie Gu, Donna McCarthy, (unknown), Shaughn H. Bryant, (unknown), (unknown), (unknown), Jamie Erickson, Saul H. Rosenberg, Annette Schwartz, Margaret Hugunin, Edit Tarcsa, Steven W. Elmore, Bradford L. McRae, Anwar Murtaza, Li‐Chun Wang, Tariq Ghayur	59
6	Apical electrolyte concentration modulates barrier function and tight junction protein localization in bovine mammary epithelium 2006 ·American Journal of Physiology-Cell Physiology ·Rebecca R. Quesnell, Jamie Erickson, Bruce D. Schultz	18
7	Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) breakdown → 2002 ·Proceedings of the National Academy of Sciences ·David Howland, Jian Liu, (unknown), (unknown), Nicholas J. Maragakis, Benjamin Kim, Jamie Erickson, John Kulik, (unknown), George Psaltis, Louis J. DeGennaro, Don W. Cleveland, Jeffrey D. Rothstein	660
8	Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells 2002 ·Microcirculation ·Michael J. Eppihimer, Jason R. Gunn, Gordon J. Freeman, Edward Greenfield, (unknown), Jamie Erickson, John P. Leonard	238
9	Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells 2002 ·Microcirculation ·Michael J. Eppihimer, Jason R. Gunn, Gordon J. Freeman, Edward Greenfield, (unknown), Jamie Erickson, John P. Leonard	21
10	Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell–dependent antitumor responses 2002 ·Blood ·Kyriaki Dunussi‐Joannopoulos, (unknown), (unknown), Robert G. Hawley, Anthony Wong, Jamie Erickson, (unknown), John P. Leonard	63
11	Alterations of intralesional and lymph node gene expression and cellular composition induced by IL‐12 administration during leishmaniasis 2001 ·Parasite Immunology ·Lisa Schopf, Jamie Erickson, Lori Hayes, Charles L. Chung, Liz M. Lavigne, Joseph P. Sypek	1
12	Efficacy and Mechanisms of Action of rmB7.2-Ig as an Antitumor Agent in Combination with Adriamycin and Cytoxan Chemotherapy 2001 ·Clinical Immunology ·(unknown), Manuel Sequeira, Mary E.P. Goad, Jamie Erickson, Anthony Wong, (unknown), Kyriaki Dunussi‐Joannopoulos, Ronald C. Li, Stuart Friedrich, Lori Hayes, Stanley F. Wolf	10
13	Interleukin-11 reduces T-cell-dependent experimental liver injury in mice 1999 ·Hepatology ·(unknown), (unknown), (unknown), Jamie Erickson, (unknown), Page Bouchard, Andrew J. Dorner, William L. Trepicchio	60
14	Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity 1999 ·Blood ·Kyriaki Dunussi‐Joannopoulos, (unknown), Jamie Erickson, Robert G. Schaub, Robert G. Hawley, John P. Leonard	40
15	Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity 1999 ·Blood ·Kyriaki Dunussi‐Joannopoulos, (unknown), Jamie Erickson, Robert G. Schaub, Robert G. Hawley, John P. Leonard	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact